(Q38223242)

31 August 2017

title

Factors impacting HPV vaccination: lessons for health care professionals (English)

1 reference

31 August 2017

1 reference

Annika M Hofstetter

1

1 reference

31 August 2017

Susan L Rosenthal

series ordinal

2

1 reference

31 August 2017

publication date

26 June 2014

1 reference

Expert Review of Vaccines

31 August 2017

published in

1 reference

31 August 2017

volume

13

1 reference

31 August 2017

issue

8

1 reference

31 August 2017

page(s)

1013-1026

1 reference

Global burden of human papillomavirus and related diseases.

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Human papillomavirus vaccine introduction--the first five years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

HPV vaccine against anal HPV infection and anal intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Answering human papillomavirus vaccine concerns; a matter of science and time

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Efficacy and other milestones for human papillomavirus vaccine introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in healthy boys aged 10-18 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Achieving high coverage in Rwanda's national human papillomavirus vaccination programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Overcoming barriers to HPV vaccination: non-inferiority of antibody response to human papillomavirus 16/18 vaccine in adolescents vaccinated with a two-dose vs. a three-dose schedule at 21 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Immunogenicity of quadrivalent HPV vaccine among girls 11 to 13 Years of age vaccinated using alternative dosing schedules: results 29 to 32 months after third dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

The Australian experience with the human papillomavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Australia leads way on HPV vaccination in boys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Human papillomavirus (HPV) vaccine policy and evidence-based medicine: are they at odds?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Drugs, sex, money and power: an HPV vaccine case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Determinants for HPV vaccine uptake in the Netherlands: A multilevel study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

A review of clinical trials of human papillomavirus prophylactic vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Early impact of human papillomavirus vaccination on cervical neoplasia--nationwide follow-up of young Danish women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Strongly decreased risk of genital warts after vaccination against human papillomavirus: nationwide follow-up of vaccinated and unvaccinated girls in Denmark.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

HPV vaccination programme in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Detection of human papillomavirus (HPV) L1 gene DNA possibly bound to particulate aluminum adjuvant in the HPV vaccine Gardasil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Coverage from Ontario, Canada's school-based HPV vaccine program: the first three years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Do correlates of HPV vaccine initiation differ between adolescent boys and girls?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

HPV vaccination: are we initiating too late?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Missed opportunities for adolescent vaccination, 2006-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Human papillomavirus vaccination in Tanzanian schoolgirls: cluster-randomized trial comparing 2 vaccine-delivery strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

HPV vaccine and males: issues and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Understanding suboptimal human papillomavirus vaccine uptake among ethnic minority girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Human papillomavirus vaccination in female pediatric cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Risk factors for non-initiation of the human papillomavirus vaccine among adolescent survivors of childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Prevalence of human papillomavirus infection in young women receiving the first quadrivalent vaccine dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Racial disparities in human papillomavirus vaccination: does access matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Exploring the role of neighborhood socio-demographic factors on HPV vaccine initiation among low-income, ethnic minority girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Predicting human papillomavirus vaccination behaviour among adolescent girls in England: results from a prospective survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Uptake of the HPV vaccination programme in England: a cross-sectional survey of young women attending sexual health services

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Integrating clinical, community, and policy perspectives on human papillomavirus vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Human papillomavirus vaccine acceptability among parents of adolescent girls: obstacles and challenges in Mysore, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Difficulties in the prevention of cervical cancer: adults' attitudes towards HPV vaccination 3 years after introducing the vaccine in Hungary

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

"HPV? Never heard of it!": a systematic review of girls' and parents' information needs, views and preferences about human papillomavirus vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

HPV vaccination among adolescent males: results from the National Immunization Survey-Teen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Risk perceptions and subsequent sexual behaviors after HPV vaccination in adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Ethnic differences in predictors of HPV vaccination: comparisons of predictors for Latina and non-Latina White women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Knowledge, attitudes, and beliefs regarding HPV vaccination: ethnic and cultural differences between African-American and Haitian immigrant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Knowledge and acceptability of the HPV vaccine among ethnically diverse black women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Ethnic differences in human papillomavirus awareness and vaccine acceptability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Knowledge, attitudes, and communication around human papillomavirus (HPV) vaccination amongst urban Asian mothers and physicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Addressing health inequalities in the delivery of the human papillomavirus vaccination programme: examining the role of the school nurse

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Singaporean women's knowledge of human papillomavirus (HPV) and attitudes toward HPV vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in US adolescent females: 2007 National Survey of Children's Health

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

A national study of HPV vaccination of adolescent girls: rates, predictors, and reasons for non-vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

The attitudes of Australian gynaecologists to HPV vaccination: an ASCCP survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

HPV vaccine decision making in pediatric primary care: a semi-structured interview study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Physicians' experiences with HPV vaccine delivery: evidence from developing country with multiethnic populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Human papillomavirus vaccination of males: attitudes and perceptions of physicians who vaccinate females.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

HPV vaccination of boys in primary care practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Human Papillomavirus Vaccination Practices: A Survey of US Physicians 18 Months After Licensure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Physicians' human papillomavirus vaccine recommendations, 2009 and 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

A national survey about human papillomavirus vaccination: what we didn't ask, but physicians wanted us to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Human papillomavirus vaccines: factors that affect vaccine knowledge and delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Influential factors in HPV vaccination uptake among providers in four states

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Qualitative responses to a national physician survey on HPV vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Chlamydia screening among young women: individual- and provider-level differences in testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Correlates of human papillomavirus vaccination rates in low-income, minority adolescents: a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Awareness of human papillomavirus infection, testing and vaccination in midwives and midwifery students in Greece

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Cancers that U.S. physicians believe the HPV vaccine prevents: findings from a physician survey, 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Vaccinating against HPV: physicians' and medical students' point of view

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

UK health professionals' attitudes and knowledge regarding Human Papillomavirus (HPV) vaccination: A West Yorkshire Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Vaccine counseling: a content analysis of patient-physician discussions regarding human papilloma virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Human papillomavirus vaccine practices in the USA: do primary care providers use sexual history and cervical cancer screening results to make HPV vaccine recommendations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Communication skills in HPV prevention: an audit among Italian healthcare workers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Patient—Provider Communication and Human Papillomavirus Vaccine Acceptance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Effects of information framing on human papillomavirus vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Predictors of STI vaccine acceptability among parents and their adolescent children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

HPV vaccination and the effect of information framing on intentions and behaviour: an application of the theory of planned behaviour and moral norm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Does framing human papillomavirus vaccine as preventing cancer in men increase vaccine acceptability?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Educational interventions to increase HPV vaccination acceptance: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Does perceived risk influence the effects of message framing? A new investigation of a widely held notion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

National health care visit patterns of adolescents: implications for delivery of new adolescent vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Parent-son decision-making about human papillomavirus vaccination: a qualitative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Understanding attitudes toward adolescent vaccination and the decision-making dynamic among adolescents, parents and providers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Utilizing health information technology to improve vaccine communication and coverage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Effectiveness of decision support for families, clinicians, or both on HPV vaccine receipt

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Increasing adolescent immunization by webinar: a brief provider intervention at federally qualified health centers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Getting it right: the impact of a continuing medical education program on hepatitis B knowledge of Australian primary care providers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

The human papillomavirus (HPV) vaccine and cervical cancer: uptake and next steps.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Behavioral interventions to increase HPV vaccination acceptability among mothers of young girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Use of multimedia as an educational tool to improve human papillomavirus vaccine acceptability--a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Effectiveness and net cost of reminder/recall for adolescent immunizations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Challenges and successes of immunization registry reminders at inner-city practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

The impact of reminder-recall interventions on low vaccination coverage in an inner-city population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Parental and provider preferences and concerns regarding text message reminder/recall for early childhood vaccinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Attitudes of pediatricians and primary health center physicians in India concerning routine immunization, barriers to vaccination, and missed opportunities to vaccinate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Delivering adolescent vaccinations in the medical home: a new era?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

The relationship between receiving care within a medical home and HPV vaccine receipt for adolescent girls: results of the 2007 National Survey of Children's Health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Influenza vaccination in adolescents with high-risk conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Are women with lupus at higher risk of HPV infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

High prevalence of oral human papillomavirus infection in Fanconi's anemia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Risky behavior in teens with cystic fibrosis or sickle cell disease: a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Health risk behaviors in adolescents with chronic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Optimizing immunization in pediatric special risk groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

HPV vaccine cross-protection: Highlights on additional clinical benefit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

HPV vaccines to prevent cervical cancer and genital warts: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Testing previous model predictions against new data on human papillomavirus vaccination program outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

Health care professional communication about STI vaccines with adolescents and parents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.933076

10.1586/14760584.2014.933076

21 January 2018

Identifiers

DOI

1 reference

31 August 2017

1 reference